Results 121 to 130 of about 27,419 (207)

FDA Adverse Event Reporting System (FAERS) Essentials: A Guide to Understanding, Applying, and Interpreting Adverse Event Data Reported to FAERS. [PDF]

Clin Pharmacol Ther
Potter E, Reyes M, Naples J, Dal Pan G.
europepmc   +1 more source

After the green light: Evaluating drugs in Phase IV studies.

Indian J Pharmacol
Meher BR, Mishra A.
europepmc   +1 more source

Anaphylaxis and glatiramer acetate. [PDF]

Mult Scler
Kim TB, Lee JY, Brinker A, Lee PR, Baldassari LE, Pimentel Maldonado DA, Hughes A, Chan V.   +7 more
europepmc   +1 more source

Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.

Archives of Internal Medicine, 2005
D. Wysowski, Lynette Swartz
semanticscholar   +1 more source

Challenges and future perspectives of enhanced passive safety surveillance of influenza vaccines in Europe. [PDF]

Ther Adv Drug Saf
Amaral de Avila Machado M, Gandhi-Banga S, Serradell L, Gallo S, Wagué S, Moore TM, Khromava A.   +6 more
europepmc   +1 more source

US Risk Evaluation and Mitigation Strategies with Elements to Assure Safe Use: A Longitudinal Analysis of REMS Modifications (2008-2022). [PDF]

Drug Saf
Morrato EH, Campagna EJ, LaCivita C, Toyserkani GA.   +3 more
europepmc   +1 more source

Safety profile and potential clinical risks of xanomeline and trospium chloride: A real-world pharmacovigilance study using FAERS. [PDF]

Neurotherapeutics
Bao Z, Liu Y, Liu Y.
europepmc   +1 more source

Real-World Outcomes of Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Results From the Final Analysis of Postmarketing Surveillance. [PDF]

Cancer Med
Kikuchi E, Nagata M, Ito T, Sato M, Ogi M, Morita M, Kajita M, Nishiyama H.   +7 more
europepmc   +1 more source

Safety and Performance of Postmarketing Breast Implants: An Integrated Review with Technovigilance Data. [PDF]

J Clin Med
Ramalho AAL, Tavares AA, da Silva HN, Navarro RF, da Silva VAVC, Melchior SC, Vicente MG, Fook MVL, Silva SML.   +8 more
europepmc   +1 more source

Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database. [PDF]

Ther Adv Drug Saf
Xiong X, Chen Z, Yan B.
europepmc   +1 more source